Medtronic 2016 Annual Report Download - page 71

Download and view the complete annual report

Please find page 71 of the 2016 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 158

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158

Table of Contents
68
Medtronic plc
Consolidated Statements of Shareholders’ Equity
Ordinary Shares Retained
Earnings
Accumulated
Other
Comprehensive
Loss
Total
Shareholders’
Equity
(in millions) Number Par Value
Balance as of April 26, 2013 1,016 $ 102 $ 19,061 $ (492) $ 18,671
Net income 3,065 3,065
Other comprehensive loss (105) (105)
Dividends to shareholders (1,116) (1,116)
Issuance of shares under stock purchase and award plans 31 3 1,304 1,307
Repurchase of ordinary shares (48) (5) (2,548) (2,553)
Tax benefit from exercise of stock-based awards 29 29
Stock-based compensation 145 145
Balance as of April 25, 2014 999 $ 100 $ 19,940 $ (597) $ 19,443
Net income 2,675 2,675
Other comprehensive loss (587) (587)
Ordinary shares issued in connection with the Covidien plc
acquisition, net of taxes 436 33,787 33,787
Result of contribution of Medtronic, Inc. to Medtronic plc (99) 99
Dividends to shareholders (1,337) (1,337)
Issuance of shares under stock purchase and award plans 17 2 647 649
Repurchase of ordinary shares (30) (3) (1,917) (1,920)
Tax benefit from exercise of stock-based awards 81 81
Stock-based compensation 439 439
Balance as of April 24, 2015 1,422 $ — $ 54,414 $ (1,184) $ 53,230
Net income 3,538 3,538
Other comprehensive loss (684) (684)
Dividends to shareholders (2,139) (2,139)
Issuance of shares under stock purchase and award plans 15 491 491
Repurchase of ordinary shares (38) (2,830) (2,830)
Tax benefit from exercise of stock-based awards 82 82
Stock-based compensation 375 375
Balance as of April 29, 2016 1,399 $ — $ 53,931 $ (1,868) $ 52,063
The accompanying notes are an integral part of these consolidated financial statements.